Celgene Corp. (CELG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 702.45m
  • Volume: 0

Latest ShareCast News

Bristol Myers acquires Celgene in $74bn pharma deal

By Iain Gilbert

Date: Thursday 03 Jan 2019

(Sharecast News) - US drugmaker Bristol-Myers Squibb reached a deal to acquire biotech group Celgene on Thursday in one of the largest acquisitions ever in the history of the pharmaceuticals industry.

Celgene Corp. ShareCast News

Juno Therapeutics surges on Celgene deal 22-Jan-2018 ShareCast
Trump calls on drug giants to boost US productio... 31-Jan-2017 ShareCast

Celgene Corp. Newspaper Links

For Biotech, a Tax Break Spells Hope 10-Dec-2008 New York Times
Celgene to buy Pharmion 19-Nov-2007 LA Times
Celgene to Acquire Pharmion 19-Nov-2007 New York Times

Celgene Corp. Tips & Analysis

Celgene Buys Rival to Get Access to Cancer Drugs 07-Dec-2009 Intl Herald Tribune
Market movers 04-Jan-2008 Chicago Tribune
Dow closes below 13,000 amid credit worries 20-Nov-2007 Wall Street Journal
Celgene to acquire Pharmion 19-Nov-2007 Intl Herald Tribune
Pfizer takes its medicine after cholesterol disa... 05-Dec-2006 The Independent

Celgene Corp. News Wires

Stock Alert: Emerging Public Company Signs Gramm... 06-Jul-2006 Marketwired
ERUG Is on the Move: Acquisition Will Bring the ... 30-May-2006 Marketwired

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Celgene Corp. Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 702.45m

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page